clinvestКачественная клиническая практикаKachestvennaya Klinicheskaya Praktika = Good Clinical Practice2588-05192618-8473ООО «Издательство ОКИclinvest-337Research ArticleПРАКТИЧЕСКИЕ РЕКОМЕНДАЦИИPRACTICAL RECOMMENDATIONSСовременные комбинированные ингаляционные препараты для лечения бронхиальной астмыСтрокА. Б.

кафедра клинической фармакологии с курсом клинической фармакологии и фармакокинетики ФУВ

clinvest@mail.ruФГБОУ ВО РНИМУ им. Н.И. Пирогова; ФГБУ РДКБ МЗ РФRussian Federation200627062018028487Copyright © Строк А.Б., 20182018Строк А.Б.Строк А.Б.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinvest.ru/jour/article/view/337

В статье описаны современные комбинированные ингаляционные препараты для лечения бронхиальной астмы, такие как Симбикорт Турбухалер и Серетид Мультидиск.

комбинированные ингаляционные препаратыбронхиальная астмаReferencesCoutts J.A.P., Gibson N.A., Paton J.Y. Measuring compliance with inhaled medication in asthma. Arch. Dis. Child. 1992. Vol. 67. P. 332-333.Coutts J.A.P., Gibson N.A., Paton J.Y. Measuring compliance with inhaled medication in asthma. Arch. Dis. Child. 1992. Vol. 67. P. 332-333.Bateman. Controlling asthma. Presented at launch seretid., Berlin, 1999.Bateman. Controlling asthma. Presented at launch seretid., Berlin, 1999.Woodcock. The rationale for Seretide. Presented at launch seretid, Berlin, 1999.Woodcock. The rationale for Seretide. Presented at launch seretid, Berlin, 1999.Masoli M., Weatherall M., Holt S., Beasley R. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax. 2005, Vol. 60 (9). P. 730-734.Masoli M., Weatherall M., Holt S., Beasley R. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax. 2005, Vol. 60 (9). P. 730-734.Kaik G. et al. Annual ERS Congress.2002 (Poster).Kaik G. et al. Annual ERS Congress.2002 (Poster).Masoli M., Williams M., Weatherall M., Beasley R. The 24h duration of bronchodilator action of the budesonide/formoterol combination inhaler. Respir. Med. 2006. Vol. 100. P. 20-25.Masoli M., Williams M., Weatherall M., Beasley R. The 24h duration of bronchodilator action of the budesonide/formoterol combination inhaler. Respir. Med. 2006. Vol. 100. P. 20-25.Vogelmeier C. D'Urso A., Pauwels R., Merino J.M., Jaspal M., Boutet S., Naya I., Price D. Budesonide/formoterol maintenence and reliver therapy: an effective asthma treatment option?//Eur. Respir. J. 2005. Vol. 26. P. 819-828.Vogelmeier C. D'Urso A., Pauwels R., Merino J.M., Jaspal M., Boutet S., Naya I., Price D. Budesonide/formoterol maintenence and reliver therapy: an effective asthma treatment option?//Eur. Respir. J. 2005. Vol. 26. P. 819-828.Johansson G., Andreasson E.B., Larsson P.E., Vogelmeier C.F. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. Pharmacoeconomics. 2006. Vol. 24 (7). P. 695-708.Johansson G., Andreasson E.B., Larsson P.E., Vogelmeier C.F. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. Pharmacoeconomics. 2006. Vol. 24 (7). P. 695-708.Ericsson K., Bantje T., Huber R. et al. Simbicort Turbuhaler is more cost effective than Fluticasone Discus in the treatment of asthma. Am. J. Respir. Crit. Care Med. 2001. Vol. 163, N 5. P. А863.Ericsson K., Bantje T., Huber R. et al. Simbicort Turbuhaler is more cost effective than Fluticasone Discus in the treatment of asthma. Am. J. Respir. Crit. Care Med. 2001. Vol. 163, N 5. P. А863.O'Sullivan S., Akveld M., Burke C.M., Poulter L.W. Effect of Montelukast to Inhaled Fluticasone Propionate on Airway Inflammation. Am. J. Respir. Crit. Care Med. 2003. Vol. 167. P. 745-750.)O'Sullivan S., Akveld M., Burke C.M., Poulter L.W. Effect of Montelukast to Inhaled Fluticasone Propionate on Airway Inflammation. Am. J. Respir. Crit. Care Med. 2003. Vol. 167. P. 745-750.)Nannini L., Cates C.J., Lasserson T.J., Poole P. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2004; 3, CD003794.Nannini L., Cates C.J., Lasserson T.J., Poole P. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2004; 3, CD003794.

The authors declare that there are no conflicts of interest present.